Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A new method to quantify left ventricular mass by 2D echocardiography

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest: A Post Hoc Analysis of the TTM Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lung ultrasound findings following COVID-19 hospitalization: A prospective longitudinal cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The aim was to translationally compare a pharmacologic strategy versus treatment with the Impella RP in profound RV cardiogenic shock (CS). The pigs were allocated to either vasoactive therapy with norepinephrine (0.10 μg/kg/min) for the first 30 min, supplemented by an infusion of milrinone (0.4 μg/kg/min) for additional 150 min, or treatment with the Impella RP device for 180 min. Total RV workload (Pressure-volume-area × heart rate*103(mmHg/min)) remained unaffected upon treatment with the Impella RP and increased in the vasoactive group (CS 179[147;228] to norepinephrine 268[247;306](p = 0.002 compared to Impella RP) and norepinephrine + milrinone 366[329;422] (p = 0.002 compared to Impella RP). A trend towards higher venous cerebral oxygen saturation was observed with norepinephrine than Impella RP (Impella RP 51[47;61]% vs norepinephrine 62[57;71]%; p = 0.07), which became significantly higher with the addition of milrinone (Impella RP 45[32;63]% vs norepinephrine + milrinone 73[66;81]%; p = 0.002). The Impella RP unloaded the failing RV. In contrast, vasoactive treatment led to enhanced cerebral venous oxygen saturation.

Original languageEnglish
JournalJournal of Cardiovascular Translational Research
Volume14
Issue number6
Pages (from-to)1021-1029
Number of pages9
ISSN1937-5387
DOIs
Publication statusPublished - Dec 2021

Bibliographical note

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

    Research areas

  • Cardiogenic shock, Hemodynamics, Impella RP, Translational science, Vasopressor, Ventricular unloading

ID: 71199909